Literature DB >> 10939718

Mycobacterium tuberculosis-secreted protein antigens: immunogenicity in baboons.

K Pehler1, K M Brasky, T M Butler, R Attanasio.   

Abstract

The effective control of tuberculosis (TB) requires the development of improved vaccines. It is now well established that Mycobacterium tuberculosis-secreted antigens represent promising candidates to be included in subunit vaccine preparations. It also is accepted that studies in nonhuman primate models will be required to further develop these vaccine preparations. As a necessary step in this direction, we have assessed the immunogenicity of M. tuberculosis-secreted antigens in baboons. Animals received a total of three intramuscular injections consisting of M. tuberculosis culture filtrate proteins resuspended in an adjuvant formulation (MPL-SE) and were tested for development of specific antibody and cellular responses. All animals produced antibody and cellular proliferative responses in the absence of detectable delayed-type hypersensitivity reactions. Production of gamma-interferon following stimulation of peripheral blood lymphocytes with culture filtrate proteins was either absent or present at low levels. Results from this study show that, although M. tuberculosis-secreted protein antigens are relatively safe and immunogenic in baboons, alternative immunization approaches must be identified for the induction of T-helper type 1 responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10939718     DOI: 10.1023/a:1017215720949

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  38 in total

1.  Improved sensitivity for detection of tuberculosis cases by a modified Anda-TB ELISA test.

Authors:  M S al-Hajjaj; M O Gad-el-Rab; I O al-Orainey; F A al-Kassimi
Journal:  Tuber Lung Dis       Date:  1999

2.  Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serology.

Authors:  A Verbon; G J Weverling; S Kuijper; P Speelman; H M Jansen; A H Kolk
Journal:  Am Rev Respir Dis       Date:  1993-08

3.  Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.

Authors:  C A Power; G Wei; P A Bretscher
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

4.  Therapy of tuberculosis in mice by DNA vaccination.

Authors:  D B Lowrie; R E Tascon; V L Bonato; V M Lima; L H Faccioli; E Stavropoulos; M J Colston; R G Hewinson; K Moelling; C L Silva
Journal:  Nature       Date:  1999-07-15       Impact factor: 49.962

Review 5.  Immunological requirements for a subunit vaccine against tuberculosis.

Authors:  M J Elhay; P Andersen
Journal:  Immunol Cell Biol       Date:  1997-12       Impact factor: 5.126

6.  Development of new vaccines for tuberculosis. Recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-08-21

7.  Global tuberculosis incidence and mortality during 1990-2000.

Authors:  P J Dolin; M C Raviglione; A Kochi
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

8.  Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis.

Authors:  A D Roberts; M G Sonnenberg; D J Ordway; S K Furney; P J Brennan; J T Belisle; I M Orme
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

9.  Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins.

Authors:  P Andersen
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Use of Mycobacterium tuberculosis complex-specific antigen cocktails for a skin test specific for tuberculosis.

Authors:  K Lyashchenko; C Manca; R Colangeli; A Heijbel; A Williams; M L Gennaro
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more
  2 in total

1.  Lymphocyte modulation in a baboon model of immunosenescence.

Authors:  Lakshmi Jayashankar; Kathleen M Brasky; John A Ward; Roberta Attanasio
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

2.  A second-generation anti TB vaccine is long overdue.

Authors:  Mauricio Castañón-Arreola; Yolanda López-Vidal
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-06-03       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.